Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors

Hironobu Minami, Kenji Kawada, Hiromichi Ebi, Koichi Kitagawa, Yon Il Kim, Kazuhiro Araki, Hirofumi Mukai, Makoto Tahara, Hikaru Nakajima, Keiko Nakajima

Research output: Contribution to journalArticlepeer-review

98 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences